4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000235
Director sold 500 shares at an average $543.09 ($271,547)
From the SEC's structured data for this filing
Trades in this filing
FOLETTA MARK G · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-01 | Sale : show line 1 in the form | −47 | $538.02 | $25,287 | 14,050 | I |
| 2021-10-01 | Sale : show line 2 in the form | −6 | $539.10 | $3,235 | 14,044 | I |
| 2021-10-01 | Sale : show line 3 in the form | −88 | $540.93 | $47,602 | 13,956 | I |
| 2021-10-01 | Sale : show line 4 in the form | −126 | $543.15 | $68,437 | 13,830 | I |
| 2021-10-01 | Sale : show line 5 in the form | −181 | $544.39 | $98,535 | 13,649 | I |
| 2021-10-01 | Sale : show line 6 in the form | −51 | $547.06 | $27,900 | 13,598 | I |
| 2021-10-01 | Sale : show line 7 in the form | −1 | $551.58 | $552 | 13,597 | I |
| Open-market sales · 500 sh · avg $543.09 · $271,547 | ||||||
Loading xslF345X03/edgardoc.xml…